Global Cardiac Biomarker Diagnostic Kits Market (2021-2026) by Product, Indication, Testing, End-User, Geography, Competitive Analysis and the Impact of Covid-19 with Ansoff Analysis

The Global Cardiac Biomarker Diagnostic Kits Market is estimated to be USD 3.2 Bn in 2021 and is expected to reach USD 5.04 Bn by 2026, growing at a CAGR of 9.5%.

Market Dynamics

Due to the increasing geriatric population, unhealthy lifestyle among individuals, high smoking & alcohol consumption inevitably leads to rising incidences of cardiovascular diseases, which is majorly driving the market growth. Other important drivers are increasing awareness of early detection of diseases coupled with rising healthcare spending in emerging countries. Additionally, the increasing popularity of point-of-care testing has boosted the market revenue. However, the low availability of cardiac biomarker diagnostic test kits to diagnose strokes is expected to hinder the market.
The rising investment from public and private organizations for research on cardiac biomarkers is anticipated to create new opportunities for the market.

Market Segmentation

The Global Cardiac Biomarker Diagnostic Kits Market is segmented further based on Product, Indication, Testing, End-User, and Geography.

By Product, the market is classified into Brain Natriuretic Peptide (BNPs) Test Kits, Creatine Kinase MB (CK-MB) Test Kits, Troponin (I&T) Tests Kits, Myoglobin Test Kits, and Other Test Kits. Amongst all, the Troponin (I&T) Tests Kits segment is estimated to hold the highest market share during the forecast period.

By Indication, the market is classified as Acute Coronary Syndrome, Acute Myocardial Infarction, Congestive Heart Failure, and Others. Amongst all, the Acute Coronary Syndrome segment is estimated to hold the highest market share during the forecast period.

By Testing, the market is classified as Laboratory Testing and Point of Care Testing. Amongst the two, the Laboratory Testing segment is estimated to hold the highest market share during the forecast period.

By End-User, the market is classified as Hospitals, Clinics, Diagnostic Laboratories, and Others. Amongst the two, the Hospitals segment is estimated to hold the highest market share during the forecast period.

By Geography, North America is projected to lead the market.

Recent Developments

1. Roche has announced a series of five new intended uses for two key cardiac biomarkers using the Elecsys technology: high sensitive cardiac troponin T (cTnT-hs) and N-terminal pro-brain natriuretic peptide test (NT-proBNP). - 29th April 2021

Company Profiles

Some of the companies covered in this report are Siemens AG, Beckman Coulter Inc., Becton, Dickinson, and Company, Life Diagnostic, Roche Diagnostic, etc.

Competitive Quadrant

The report includes Competitive Quadrant, a proprietary tool to analyze and evaluate the position of companies based on their Industry Position score and Market Performance score. The tool uses various factors for categorizing the players into four categories. Some of these factors considered for analysis are financial performance over the last 3 years, growth strategies, innovation score, new product launches, investments, growth in market share, etc.

Why buy this report?

• The report offers a comprehensive evaluation of the Global Cardiac Biomarker Diagnostic Kits Market. The report includes in-depth qualitative analysis, verifiable data from authentic sources, and projections about market size. The projections are calculated using proven research methodologies.
• The report has been compiled through extensive primary and secondary research. The primary research is done through interviews, surveys, and observation of renowned personnel in the industry.
• The report includes an in-depth market analysis using Porter’s 5 forces model and the Ansoff Matrix. In addition, the impact of Covid-19 on the market is also featured in the report.
• The report also includes the regulatory scenario in the industry, which will help you make a well-informed decision. The report discusses major regulatory bodies and major rules and regulations imposed on this sector across various geographies.
• The report also contains the competitive analysis using Positioning Quadrants, the analyst’s Proprietary competitive positioning tool.

Report Highlights:

• A complete analysis of the market, including parent industry
• Important market dynamics and trends
• Market segmentation
• Historical, current, and projected size of the market based on value and volume
• Market shares and strategies of key players
• Recommendations to companies for strengthening their foothold in the market